| Haiyang Guo | Princess Margaret Cancer Center, University Health Network |
| Musaddeque Ahmed | Princess Margaret Cancer Center, University Health Network |
| Fan Zhang | Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai |
| Cindy Q Yao | Ontario Institute for Cancer Research |
| SiDe Li | Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai |
| Yi Liang | Princess Margaret Cancer Center, University Health Network |
| Junjie T Hua | Princess Margaret Cancer Center, University Health Network |
| Junjie T Hua | University of Toronto |
| Fraser Soares | Princess Margaret Cancer Center, University Health Network |
| Yifei Sun | Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai |
| Jens Langstein | Princess Margaret Cancer Center, University Health Network |
| Jens Langstein | German Cancer Research Center (DKFZ) |
| Yuchen Li | Princess Margaret Cancer Center, University Health Network |
| Christine Poon | Princess Margaret Cancer Center, University Health Network |
| Swneke D Bailey | Princess Margaret Cancer Center, University Health Network |
| Kinjal Desai | Norris Cotton Cancer Center, Dartmouth Medical School |
| Fei Teng | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Qiyuan Li | Medical College of Xiamen University |
| Dorota H Sendorek | Ontario Institute for Cancer Research |
| Michael Fraser | Princess Margaret Cancer Center, University Health Network |
| John R Prensner | Michigan Center for Translational Pathology, University of Michigan Medical School ann arbor |
| John R Prensner | Michigan Center for Translational Pathology, University of Michigan Medical School ann arbor |
| Trevor J Pugh | Princess Margaret Cancer Center, University Health Network |
| Trevor J Pugh | University of Toronto |
| Trevor J Pugh | Princess Margaret Cancer Center, University Health Network |
| Trevor J Pugh | University of Toronto |
| Mark M Pomerantz | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Mark M Pomerantz | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Robert G Bristow | Princess Margaret Cancer Center, University Health Network |
| Robert G Bristow | University of Toronto |
| Mathieu Lupien | Princess Margaret Cancer Center, University Health Network |
| Mathieu Lupien | Ontario Institute for Cancer Research |
| Mathieu Lupien | University of Toronto |
| Felix Y Feng | University of California at San Francisco |
| Felix Y Feng | University of California at San Francisco |
| Felix Y Feng | University of California at San Francisco |
| Felix Y Feng | Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco |
| Paul C Boutros | Ontario Institute for Cancer Research |
| Paul C Boutros | University of Toronto |
| Paul C Boutros | University of Toronto |
| Matthew L Freedman | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Matthew L Freedman | Eli and Edythe L. Broad Institute |
| Matthew L Freedman | Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute |
| Matthew L Freedman | Eli and Edythe L. Broad Institute |
| Martin J Walsh | Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai |
| Martin J Walsh | Icahn School of Medicine at Mount Sinai |
| Housheng Hansen He | Princess Margaret Cancer Center, University Health Network |
| Housheng Hansen He | University of Toronto |